🚀 We are thrilled to announce that ArgusEye has been awarded the prestigious Bio-X Accelerate grant! 🎉 This significant support will propel our innovation to new heights. With the added resources: * We will accelerate the development of an in-line probe for the upstream process of biologics. * Our advancements will include sensor chips designed for continuous measurements throughout the entire bioprocess cycle. * This addition to our product portfolio will significantly enhance ArgusEye's offering, enabling comprehensive in-line data coverage across the entire bioprocess chain. This acceleration aligns perfectly with our mission: transforming bioprocessing through real-time data. With this injection of resources, we are one step closer to revolutionizing how bioprocessing is done, ensuring more efficient and effective outcomes in the industry. We thank STUNS Life science for selecting us and extend our heartfelt congratulations to our fellow winners: Strike Pharma AB, Rarity Bioscience , Readily Diagnostics, and Phenaros Pharmaceuticals. The goals of the Bio-X Accelerate program are to fast-track innovation in the health and life science industries, and we are honored to be part of this transformative initiative. The kick-off is set for this autumn, and you can join us during the pitch event here: https://lnkd.in/diurc_gd #Innovation #Bioprocessing #RealTimeData #BioXAccelerate #Healthcare #LifeSciences #ArgusEye
Jennie Ekbeck
3mo
Grattis 🥳
Congratulations! 👏